Ariad Pharmaceuticals News
Most Popular Ariad Pharmaceuticals Story
Ponatinib - 10 promising late-stage cancer drugs
The big story at Cambridge, MA-based Ariad Pharmaceuticals ($ARIA) is its leukemia drug ponatinib, despite the fact that its lead experimental cancer drug is ridaforolimus (which is advancing in Read more...
Latest Headlines
- April 4, 2011
- March 30, 2011
- July 14, 2010
- December 8, 2009
- July 28, 2009
- September 12, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
